Leukemia Home > Cancer and Clolar

Children and young adults who have a certain type of cancer may receive Clolar® (clofarabine). It is specially approved to treat a type of bone marrow and blood cell cancer called acute lymphoblastic leukemia (ALL). It is used after at least two other treatment regimens were tried but did not work adequately. Clolar is approved for use in children age 1 to 21 years old.
Clolar works by interfering with the way DNA replicates. Because cells need DNA to grow and divide, this medication can prevent the growth of cancer cells.
There are also some unapproved, or "off-label," uses for Clolar, such as treating:
  • Acute myelocytic leukemia
  • Myelodysplastic syndrome
  • Chronic myeloid leukemia.
(Click Clolar Uses for more information on using this drug for cancer treatment. This article also offers detailed information on how Clolar works and whether it is prescribed for adults.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):



Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.